Patent details

Basic Information

Publication number:

EP3678687

PCT Application Number:

IB2018001112

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP188525109

PCT Publication Number:

WO2019043457

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

MUTANT FGF-21 PEPTIDE CONJUGATES AND USES THEREOF

French Title of Invention:

CONJUGUÉS DE PEPTIDE FGF-21 MUTANT ET LEURS UTILISATIONS

German Title of Invention:

MUTIERTE FGF-21-PEPTID-KONJUGATE UND VERWENDUNGEN DAVON

SPC Number:

Dates

Filing date:

04/09/2018

Grant date:

17/08/2022

EP Publication Date:

15/07/2020

PCT Publication Date:

07/03/2019

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

17/08/2022

EP B1 Publication Date:

17/08/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

04/09/2022

Expiration date:

04/09/2038

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

10/08/2022

 

 

Name:

89Bio Ltd.

Address:

6 Hamada Street, 673340 Herzliya, Israel (IL)

Inventor

1

Name:

LIU, Patrick, Mengyuan

Address:

United States (US)

2

Name:

KOPEC, Karla, K.

Address:

United States (US)

Priority

Priority Number:

201762553970 P

Priority Date:

04/09/2017

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/18; A61P 3/10; A61P 9/10; A61P 17/00; A61P 17/02; A61P 27/02; C07K 14/50; C12P 21/00;

Publication

European Patent Bulletin

Issue number:

202233

Publication date:

17/08/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages